The Relationship Between the Ganglion Cell–Inner Plexiform Layer, Retinal Nerve Fiber Layer, and Photopic Negative Response in Newly Diagnosed Pituitary Macroadenoma: 12-Month Prospective Follow-Up Study
Cancers · 01.05.2025 · 17 (9) · 1542
DOI: 10.3390/cancers17091542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 01.05.2025. Verfasst von Monika Sarnat-Kucharczyk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
Background/Objectives: This prospective study evaluates the relationship between the ganglion cell–inner plexiform layer (GCIPL), retinal nerve fiber layer (RNFL), and photopic negative response (PhNR) in patients with newly diagnosed pituitary macroadenomas over 12 months.
Methods
A total of 40 patients (80 eyes) were included, divided into a treatment group of 27 patients (54 eyes), receiving pharmacological and/or surgical intervention, and an observation group of 13 patients (26 eyes), with non-functional pituitary adenomas (NFPAs) that did not require treatment.
Results
Key findings indicate a significant improvement in best corrected visual acuity (BCVA) after 12 months in the treatment group (p = 0.02) and a significant reduction in RNFL thickness in multiple quadrants (p < 0.01). Moreover, PhNR amplitude and W-ratio significantly increased in the treatment group (p < 0.0001). In the observation group, only GCIPL Inferior (p = 0.0470) and PhNR W-ratio (p = 0.0015) showed significant differences. Between-group comparisons showed significant differences in RNFL Nasal quadrant at baseline (p = 0.0017) and after 12 months (p = 0.0150). PhNR amplitude and W-ratio also differed significantly between groups at 12 months (p = 0.0012 and p = 0.0016, respectively). Correlations between OCT and ERG parameters were weak at baseline and diminished over time.
Conclusions
These findings suggest that GCIPL, RNFL, and PhNR analyses may be useful for monitoring disease progression and guiding treatment decisions in patients with pituitary macroadenomas.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
- Kornel Gibinski University Clinical Centre, 40-514 Katowice, Poland.
- Department of Endocrinology and Neuroendocrine Tumors, Medical University of Silesia, 40-514 Katowice, Poland.
- Institute of Biomedical Engineering, Faculty of Science and Technology, University of Silesia in Katowice, 41-205 Sosnowiec, Poland.
ORCID-Profile: Monika Sarnat-Kucharczyk, Dorota Pojda-Wilczek, Ewa Mrukwa-Kominek, Beata Kos-Kudła, Małgorzata A Janik, Paweł Janik
Förderung
- Medical University of Silesia
Zitieren
APA
Sarnat-Kucharczyk, M., Pojda-Wilczek, D., Mrukwa-Kominek, E., Kos-Kudła, B., Janik, M. A., & Janik, P. (2025). The Relationship Between the Ganglion Cell–Inner Plexiform Layer, Retinal Nerve Fiber Layer, and Photopic Negative Response in Newly Diagnosed Pituitary Macroadenoma: 12-Month Prospective Follow-Up Study. Cancers, 17(9), 1542. https://doi.org/10.3390/cancers17091542
Vancouver
Sarnat-Kucharczyk M, Pojda-Wilczek D, Mrukwa-Kominek E, Kos-Kudła B, Janik MA, Janik P. The Relationship Between the Ganglion Cell–Inner Plexiform Layer, Retinal Nerve Fiber Layer, and Photopic Negative Response in Newly Diagnosed Pituitary Macroadenoma: 12-Month Prospective Follow-Up Study. Cancers. 2025;17(9):1542. doi:10.3390/cancers17091542
BibTeX
@article{SarnatKucharczyk2025,
author = {Sarnat-Kucharczyk, Monika and Pojda-Wilczek, Dorota and Mrukwa-Kominek, Ewa and Kos-Kudła, Beata and Janik, Małgorzata A and Janik, Paweł},
title = {The Relationship Between the Ganglion Cell–Inner Plexiform Layer, Retinal Nerve Fiber Layer, and Photopic Negative Response in Newly Diagnosed Pituitary Macroadenoma: 12-Month Prospective Follow-Up Study},
journal = {Cancers},
year = {2025},
volume = {17},
number = {9},
pages = {1542},
doi = {10.3390/cancers17091542}
}
EUVIMED